BUYINS.NET: GPCB, INSG, UGHO, ZFPI Have Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days
Mar 27, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold lists for 13 consecutive trading days: Gpc Biotech Ag (NASDAQ: GPCB), Insignia Solutions, plc (NASDAQ: INSG), Universal Guardian Holdings, Inc (OTCBB: UGHO), Zone 4 Play, Inc. (OTCBB: ZFPI). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.
Regulation SHO took effect January 3, 2005, and provides a new regulatory framework governing short selling of securities. It was designed with the objective of simplifying and modernizing short sale regulation and providing controls where they are most needed. At the conclusion of each settlement day, data is provided on securities in which: 1) there are at least 10,000 shares in aggregate failed deliveries for the security for five consecutive settlement days, and 2) these failures constitute at least 0.5% of the issuer's total shares outstanding. Regulation SHO mandates that, if a clearing agent has had a fail-to-deliver position for 13 consecutive settlement days, that clearing agent, and the broker/dealer it clears for, must purchase securities to close out its fail to deliver position.
Gpc Biotech Ag (NASDAQ: GPCB) a biopharmaceutical company, engages in the discovery and development of drugs to treat cancer. Its lead product candidate is satraplatin, an oral platinum-based compound intended for use as a chemotherapy drug. Satraplatin is being evaluated in a phase III registrational trial for second-line treatment of hormone refractory prostate cancer. The company's second product candidate, 1D09C3, is a monoclonal antibody intended for the treatment of selected leukemias and lymphomas, including nonHodgkin's lymphoma. Its another product candidate, RGB-286199, is a lead compound in a family of small molecule compounds that inhibit the cell cycle, which is essential for tumor growth. RGB-286199 is in preclinical development. GPC Biotech has a strategic alliance with ALTANA Pharma AG, which encompasses a technology transfer component, as well as research collaboration; and a co-development and license agreement with Pharmion Corp. for satraplatin, the oral platinum-based compound in advanced clinical development. The company was co-founded by Elmar Maier, Mirko Scherer, Sebastian Meier-Ewert, and David R. Bancroft as RM 102 Vermgensverwaltungs GmbH in January 1997 and changed its name to Genome Pharmaceuticals Corporation GmbH in August 1997. The name was further changed to GPC Aktiengesellschaft Genome Pharmaceuticals Corporation in 1998 and to GPC Biotech AG in 2000. GPC Biotech is headquartered in Munich, Germany. With 30.12 million shares outstanding and 878 shares declared short as of February 2006, the failure to deliver in shares of GPCB has not been resolved and a buy-in is imminent.
Insignia Solutions, plc (NASDAQ: INSG) engages in the development, marketing, and support of software technologies that enable mobile operators and phone manufacturers to update the firmware of mobile devices using standard over-the-air data networks. The company primarily offers secure system provisioning (SSP) product line, which is an open software system that enables mobile operators and terminal manufacturers to repair the system software on their subscribers' terminals, as well as add other capabilities over-the-air. Insignia Solutions sells and markets its SSP products primarily to mobile operators and device manufacturers through direct channels and original equipment manufacturers in the United States and the United Kingdom. It has strategic alliances with International Business Machines Corp. and Symbian. The company was incorporated as Diplema Ninety Three Limited in 1985 and changed its name to Insignia Solutions Limited in 1986. Further, Insignia Solutions Limited changed its name to Insignia Solutions plc in 1995. Insignia Solutions is headquartered in Fremont, California. With 42.5 million shares outstanding and 121,801 shares declared short as of February 2006, the failure to deliver in shares of INSG has not been resolved and a buy-in is imminent.
Universal Guardian Holdings, Inc (OTCBB: UGHO) a holding company, provides security products and services to mitigate terrorist, criminal, and security threats for governments and businesses worldwide. Its security services include maritime and port security; threat and vulnerability assessments; security planning and system design; executive protection and travel risk management; tactical armed security; assets in transit; crisis management; contingency planning; incident management and evacuation; executive and diplomatic protection and training; physical security training; weapons and self-defense training; and government training. The company's products include Cobra StunLight, a device to illuminate suspect and spray pepper; Riot Defender Projectile Launcher, a carbon dioxide powered air pistol; and ISR Systems Security Platform, which develop site-specific security devices. Its products provide protection for buildings and facilities, including embassies, ports, airports, jails, and border crossings. Universal Guardian Holdings is based in Newport Beach, California. With 41.22 million shares outstanding and an undisclosed short position, the failure to deliver in shares of UGHO has not been resolved and a buy-in is possible.
Zone 4 Play, Inc. (OTCBB: ZFPI) engages in the development and marketing of interactive games applications for Internet, portable devices, and interactive TV platforms. The company develops interactive games technology that provides an end-to-end solution for multiple platforms, interactive TV, mobile phones, and the Internet, allowing service providers to deliver games to their subscribers. Its technology provides play-for-fun interactive games and play-for-real gaming. The company's customers include cable and satellite television companies, wireless operators, Internet service providers, and hospitality service providers. Zone 4 Play sells its products principally in the United Kingdom and the United states. The company was founded by Shimon Citron. Zone 4 Play was incorporated in 2001 and is headquartered in Wilmington, Delaware. With 23.93 million shares outstanding and an undisclosed short position, the failure to deliver in shares of ZFPI has not been resolved and a buy-in is possible.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 650,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2006 M2 COMMUNICATIONS LTD
-0-
News 
Market Data 
Discover 
AI
